Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert G. L. Shorr currently holds 45,731 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert G. L. Shorr has been a net seller of BCLI stock. They have purchased $0 and sold $205.3K worth of shares.
Robert G. L. Shorr's most recent insider trade was on Nov 10, 2017, when they sold 8,666 shares at $0.00 per share.
Robert G. L. Shorr serves as Executive at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have executed 27 insider transactions totaling $205.3K over their tenure at the company.
Robert G. L. Shorr holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert G. L. Shorr has shown a selling trading pattern, with $0 in total purchases and $205.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert G. L. Shorr was on Oct 4, 2011, when they sold $32.5K worth of BCLI shares. This transaction involved 105,000 shares at $0.31 per share.
Robert G. L. Shorr currently owns 45,731 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert G. L. Shorr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert G. L. Shorr has 27 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC..
Set alerts for Robert G. L. Shorr and 40,000+ other insiders.